314 related articles for article (PubMed ID: 36720061)
1. Advanced Compounding: Compounding with Microneedle Arrays, Part 3: Microneedle Array Development in the Literature and Quality Control of Microneedle Arrays.
Allen LV
Int J Pharm Compd; 2023; 27(1):30-37. PubMed ID: 36720061
[TBL] [Abstract][Full Text] [Related]
2. Hydrogel-Forming Microneedle Arrays for Enhanced Transdermal Drug Delivery.
Donnelly RF; Singh TR; Garland MJ; Migalska K; Majithiya R; McCrudden CM; Kole PL; Mahmood TM; McCarthy HO; Woolfson AD
Adv Funct Mater; 2012 Dec; 22(23):4879-4890. PubMed ID: 23606824
[TBL] [Abstract][Full Text] [Related]
3. Versatility of hydrogel-forming microneedles in in vitro transdermal delivery of tuberculosis drugs.
Anjani QK; Permana AD; Cárcamo-Martínez Á; Domínguez-Robles J; Tekko IA; Larrañeta E; Vora LK; Ramadon D; Donnelly RF
Eur J Pharm Biopharm; 2021 Jan; 158():294-312. PubMed ID: 33309844
[TBL] [Abstract][Full Text] [Related]
4. Current trends in polymer microneedle for transdermal drug delivery.
Ahmed Saeed Al-Japairai K; Mahmood S; Hamed Almurisi S; Reddy Venugopal J; Rebhi Hilles A; Azmana M; Raman S
Int J Pharm; 2020 Sep; 587():119673. PubMed ID: 32739388
[TBL] [Abstract][Full Text] [Related]
5. Basics of Compounding: Compounding with Microneedle Arrays, Part 1: Introduction and Overview.
Allen LV
Int J Pharm Compd; 2022; 26(5):400-408. PubMed ID: 36053767
[TBL] [Abstract][Full Text] [Related]
6. Optimizing microneedle arrays to increase skin permeability for transdermal drug delivery.
Al-Qallaf B; Das DB
Ann N Y Acad Sci; 2009 Apr; 1161():83-94. PubMed ID: 19426308
[TBL] [Abstract][Full Text] [Related]
7. A key role by polymers in microneedle technology: a new era.
Rajput A; Kulkarni M; Deshmukh P; Pingale P; Garkal A; Gandhi S; Butani S
Drug Dev Ind Pharm; 2021 Nov; 47(11):1713-1732. PubMed ID: 35332822
[TBL] [Abstract][Full Text] [Related]
8. Optimizing microneedle arrays for transdermal drug delivery: extension to non-square distribution of microneedles.
Al-Qallaf B; Das DB
J Drug Target; 2009 Feb; 17(2):108-22. PubMed ID: 19016071
[TBL] [Abstract][Full Text] [Related]
9. Compounding with Microneedle Arrays, Part 2: Preparation and Administration Methods.
Allen LV
Int J Pharm Compd; 2022; 26(6):490-495. PubMed ID: 36445768
[TBL] [Abstract][Full Text] [Related]
10. Microneedles as an alternative technology for transdermal drug delivery systems: a patent review.
Queiroz MLB; Shanmugam S; Santos LNS; Campos CA; Santos AM; Batista MS; Araújo AAS; Serafini MR
Expert Opin Ther Pat; 2020 Jun; 30(6):433-452. PubMed ID: 32164470
[No Abstract] [Full Text] [Related]
11. Spatially controlled coating of continuous liquid interface production microneedles for transdermal protein delivery.
Caudill CL; Perry JL; Tian S; Luft JC; DeSimone JM
J Control Release; 2018 Aug; 284():122-132. PubMed ID: 29894710
[TBL] [Abstract][Full Text] [Related]
12. Microneedles for transdermal drug delivery.
Prausnitz MR
Adv Drug Deliv Rev; 2004 Mar; 56(5):581-7. PubMed ID: 15019747
[TBL] [Abstract][Full Text] [Related]
13. Transdermal delivery of relatively high molecular weight drugs using novel self-dissolving microneedle arrays fabricated from hyaluronic acid and their characteristics and safety after application to the skin.
Liu S; Jin MN; Quan YS; Kamiyama F; Kusamori K; Katsumi H; Sakane T; Yamamoto A
Eur J Pharm Biopharm; 2014 Feb; 86(2):267-76. PubMed ID: 24120887
[TBL] [Abstract][Full Text] [Related]
14. Nanoemulsion-based dissolving microneedle arrays for enhanced intradermal and transdermal delivery.
Nasiri MI; Vora LK; Ershaid JA; Peng K; Tekko IA; Donnelly RF
Drug Deliv Transl Res; 2022 Apr; 12(4):881-896. PubMed ID: 34939170
[TBL] [Abstract][Full Text] [Related]
15. Development and characterisation of novel poly (vinyl alcohol)/poly (vinyl pyrrolidone)-based hydrogel-forming microneedle arrays for enhanced and sustained transdermal delivery of methotrexate.
Tekko IA; Chen G; Domínguez-Robles J; Thakur RRS; Hamdan IMN; Vora L; Larrañeta E; McElnay JC; McCarthy HO; Rooney M; Donnelly RF
Int J Pharm; 2020 Aug; 586():119580. PubMed ID: 32593650
[TBL] [Abstract][Full Text] [Related]
16. Hydrogel-forming microneedle arrays as a therapeutic option for transdermal esketamine delivery.
Courtenay AJ; McAlister E; McCrudden MTC; Vora L; Steiner L; Levin G; Levy-Nissenbaum E; Shterman N; Kearney MC; McCarthy HO; Donnelly RF
J Control Release; 2020 Jun; 322():177-186. PubMed ID: 32200001
[TBL] [Abstract][Full Text] [Related]
17. An overview on the advantages and limitations of 3D printing of microneedles.
Ozyilmaz ED; Turan A; Comoglu T
Pharm Dev Technol; 2021 Nov; 26(9):923-933. PubMed ID: 34369288
[TBL] [Abstract][Full Text] [Related]
18. Fabrication, Physicochemical Characterization, and Performance Evaluation of Biodegradable Polymeric Microneedle Patch System for Enhanced Transcutaneous Flux of High Molecular Weight Therapeutics.
Shah V; Choudhury BK
AAPS PharmSciTech; 2017 Nov; 18(8):2936-2948. PubMed ID: 28432615
[TBL] [Abstract][Full Text] [Related]
19. Evaluation needle length and density of microneedle arrays in the pretreatment of skin for transdermal drug delivery.
Yan G; Warner KS; Zhang J; Sharma S; Gale BK
Int J Pharm; 2010 May; 391(1-2):7-12. PubMed ID: 20188808
[TBL] [Abstract][Full Text] [Related]
20. Touch-actuated microneedle array patch for closed-loop transdermal drug delivery.
Yang J; Chen Z; Ye R; Li J; Lin Y; Gao J; Ren L; Liu B; Jiang L
Drug Deliv; 2018 Nov; 25(1):1728-1739. PubMed ID: 30182757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
